Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice-Reference-Cited by-同舟云学术

Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice

Published:2017-06 Issue: Volume:261 Page:44-51
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Jojima Teruo^ORCID,Uchida Kohsuke,Akimoto Kazumi,Tomotsune Takanori,Yanagi Kazunori,Iijima Toshie,Suzuki Kunihiro,Kasai Kikuo,Aso Yoshimasa

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Atherosclerosis–an inflammatory disease;Ross;N. Engl. J. Med.,1999

2. Role of smooth muscle cells in the initiation and early progression of atherosclerosis;Doran;Arterioscler. Thromb. Vasc. Biol.,2008

3. Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling;Lafont;Circ. Res.,1995

4. The role of angiotensin II in vascular smooth muscle cell growth;Naftilan;J. Cardiovasc Pharmacol.,1992

5. Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions;Natarajan;Hypertension,1999

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension;Clinical Hypertension;2024-09-01

2. Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs;Journal of Clinical Medicine;2024-08-09

3. Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease;Journal of the Endocrine Society;2024-07-01

4. GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage;American Journal of Physiology-Heart and Circulatory Physiology;2024-05-01

5. Therapy Combining Glucagon-Like Peptide-1 Receptor Agonist with Sodium-Glucose Cotransporter 2 Inhibitor Suppresses Atherosclerosis in Diabetic ApoE-Deficient Mice;Experimental and Clinical Endocrinology & Diabetes;2024-04-16